Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab

Cancer Immunology Immunotherapy ◽

10.1007/s00262-021-03108-x ◽

2021 ◽

Author(s):

Mathilde Bureau ◽

Thierry Chatellier ◽

Tanguy Perennec ◽

Thomas Goronflot ◽

Charlotte Greilsamer ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Prognostic Factor ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Tumour Size ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients

Download Full-text

EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non–Small Cell Lung Cancer Patients

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000282 ◽

2016 ◽

pp. 1 ◽

Cited By ~ 3

Author(s):

Yong Won Choi ◽

So Yeon Jeon ◽

Geum Sook Jeong ◽

Hyun Woo Lee ◽

Seong Hyun Jeong ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Exon 19 Deletion ◽

Exon 19

Download Full-text

Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy

Lung Cancer ◽

10.1016/j.lungcan.2017.10.018 ◽

2017 ◽

Vol 114 ◽

pp. 70-78 ◽

Cited By ~ 6

Author(s):

Jie Shen ◽

Yuanqing Ye ◽

David W. Chang ◽

Maosheng Huang ◽

John V. Heymach ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Metabolite Profiles ◽

Line Chemotherapy

Download Full-text

Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum

Lung Cancer ◽

10.1016/j.lungcan.2018.01.011 ◽

2018 ◽

Vol 118 ◽

pp. 90-96 ◽

Cited By ~ 3

Author(s):

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Tzu-Hsiu Tsai ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Combined Effect ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients

Download Full-text

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

OncoImmunology ◽

10.1080/2162402x.2020.1865670 ◽

2021 ◽

Vol 10 (1) ◽

pp. 1865670

Author(s):

Wei Nie ◽

Lu Gan ◽

Xin Wang ◽

Kai Gu ◽

Fang-Fei Qian ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Is Overall Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy Affected by Dose to the Heart?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1799 ◽

2016 ◽

Vol 96 (2) ◽

pp. E465-E466

Author(s):

T. Schytte ◽

T.B. Nielsen ◽

C. Brink ◽

O. Hansen

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis

Journal of Experimental & Clinical Cancer Research ◽

10.1186/1756-9966-32-45 ◽

2013 ◽

Vol 32 (1) ◽

pp. 45 ◽

Cited By ~ 22

Author(s):

Yunzhen Chen ◽

Haichun Liu ◽

Wenliang Wu ◽

Yi Li ◽

Jianmin Li

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Bone Metastasis ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Genetic Variants ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Temporal Trends in Demographics and Overall Survival of Non–Small-Cell Lung Cancer Patients at Moffitt Cancer Center from 1986 to 2008

Cancer Control ◽

10.1177/107327481402100107 ◽

2014 ◽

Vol 21 (1) ◽

pp. 51-56 ◽

Cited By ~ 22

Author(s):

Matthew B. Schabath ◽

Zachary J. Thompson ◽

Jhanelle E. Gray

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Temporal Trends ◽

Small Cell ◽

Cancer Center ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Baseline Population Characteristics And The Association Between Progression-Free Survival And Overall Survival In Advanced Non-Small Cell Lung Cancer Patients

Value in Health ◽

10.1016/j.jval.2017.08.134 ◽

2017 ◽

Vol 20 (9) ◽

pp. A420-A421

Author(s):

M Kulakova ◽

M Hashim ◽

B Pfeiffer ◽

M Postma ◽

B Heeg

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Progression Free Survival ◽

Small Cell ◽

Population Characteristics ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD-1/PD-L1 Antibodies

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.07.017 ◽

2016 ◽

Vol 11 (11) ◽

pp. 1927-1939 ◽

Cited By ~ 29

Author(s):

Takehito Shukuya ◽

Keita Mori ◽

Joseph M. Amann ◽

Erin M. Bertino ◽

Gregory A. Otterson ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Progression Free Survival ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy

Thrombosis Research ◽

10.1016/j.thromres.2021.10.014 ◽

2021 ◽

Author(s):

Hailey Hill ◽

Myra Robinson ◽

Lauren Lu ◽

Daniel Slaughter ◽

Asim Amin ◽

...

Keyword(s):

Risk Factors ◽

Lung Cancer ◽

Venous Thromboembolism ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Systemic Therapy ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients

Download Full-text